Kolexia
Burcoveanu Domnita Oncologie médicale
Burcoveanu Domnita
Oncologie médicale
Centre Hospitalier De Bligny
Briis-sous-Forges, France
50 Activités
0 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Tumeurs embryonnaires et germinales Tumeurs du testicule Carcinome pulmonaire non à petites cellules Récidive tumorale locale Carcinome pulmonaire à petites cellules Métastase lymphatique Tumeurs du poumon {{person.topmesh9.name}} {{person.topmesh10.name}}

Collaborateurs

Voir plus
Sellam Zineb
Sellam Zineb
Centre Hospitalier Intercommunal Créteil, Créteil, France
Azancot Vidal
Azancot Vidal
Azancot, Arpajon, France
Bruel Sébastien
Bruel Sébastien
Selarl Sebastien Bruel, Arpajon, France
Bouaita Ryan
Bouaita Ryan
Scp Crome, Ris-Orangis, France

Industries

Voir plus
Schlesinger Group France
20 collaboration(s)
Dernière en 2022
ConsuMed Research
19 collaboration(s)
Dernière en 2021
M3 Global Research Ltd
8 collaboration(s)
Dernière en 2021
Inter-View Partners France
6 collaboration(s)
Dernière en 2021

Dernières activités

Voir plus
PD-28 Long-term efficacy and safety of larotrectinib in patients with tropomyosin receptor kinase (TRK) fusion gastrointestinal (GI) cancer: An updated analysis
Abstract Book of the ESMO 25th World Congress on Gastrointestinal Cancer 2023, Barcelona, Spain, 28 June - 1 July 2023   01 juin 2023
Combining gemcitabine, cisplatin, and ifosfamide (GIP) is active in patients with relapsed metastatic germ-cell tumors (GCT): a prospective multicenter GETUG phase II trial.
Annals of oncology : official journal of the European Society for Medical Oncology   04 mars 2014
Systematic review and meta-analysis of randomised, phase II/III trials adding bevacizumab to platinum-based chemotherapy as first-line treatment in patients with advanced non-small-cell lung cancer.
Annals of oncology : official journal of the European Society for Medical Oncology   23 novembre 2012
The TAXIF II Protocol Final Results: A Phase II Trial of High-Dose Chemotherapy Supported by Haematopoietic Stem Cell Transplantation in Patients with Disseminated Germ-Cell Tumors Failing Chemotherapy and with Adverse Prognostic Factors
Abstract Book of the 37th ESMO Congress Vienna, Austria, 28 September - 2 October 2012   01 septembre 2012
{{person.lastact5.name}}
{{person.lastact5.jour}}   {{person.lastact5.date}}
{{person.lastact6.name}}
{{person.lastact6.jour}}   {{person.lastact6.date}}
{{person.lastact7.name}}
{{person.lastact7.jour}}   {{person.lastact7.date}}
{{person.lastact8.name}}
{{person.lastact8.jour}}   {{person.lastact8.date}}
{{person.lastact9.name}}
{{person.lastact9.jour}}   {{person.lastact9.date}}
{{person.lastact10.name}}
{{person.lastact10.jour}}   {{person.lastact10.date}}